Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Innovative ideas from across the Oxford University Hospital Trust have received expert support in a bid to help them realise their patient potential.

Four projects have been supported by the inaugural OUH Innovation Challenge ranging from a novel walking aid design to a new biomaterial to repair soft tissue.

Trust non-executive director Chris Goard, who chaired the assessment panel, said: “Innovation is at the heart of improving healthcare and is a key strength of Oxford University Hospitals. All our staff play a vital role in delivering care and it is their expertise and experience that gives rise to brilliant ideas. This competition, open to everyone, is about tapping into that and giving great ideas the support they need to get to next level.  Ultimately, it is ideas like these that will benefit patients and clinical teams. The innovation we saw from across the Trust was outstanding.

The competition was open to all OUH staff and is part of OUH’s drive to increase awareness of innovation and to build links with industrial partners.  The aim was to develop solutions for unmet medical needs and to improve the OUH services for patients. 

All ideas are eligible for support and can include medical devices, diagnostic tools, computer software, guidelines or training packages, or questionnaires quantifying patient outcomes. The ideas must be able to be developed with an industry partner.

Supported projects in the 2014 Challenge were:

  • An acute referrals system to document and manage acute, specialist referrals between different healthcare organisations (Nick de Pennington, Specialist Registrar, Neurosurgery; Lauren Morgan, Human Factors Research Scientist)
  • Nanofibrous yarns - low cost fabrication of a new generation of implantable medical fibres to stimulate repair of soft tissue (Pierre-Alexis Mouthuy, Post Doc Researcher ; Andrew Carr, Orthopaedic Surgeon, NOC)
  •  An innovative walking aid device (Simon Wood, Senior Physiotherapist, NOC)
  • A knee stress x-ray device (Thomas Hamilton, Clinical Research Fellow, NOC)

The teams will now be given support to progress their ideas to the next stage. The competition provides financial support and mentoring.

Shortlisted entries were assessed by a panel including Mr Goard, Nick Edwards (Oxford Academic Health Science Network), Dr Ian Reckless (OUH Clinical Director, Neurosciences), Glenn Wells (OUH Associate Director of Research and Development) and Victoria Bates (Customer Operations Director, Pfizer) The competition is set to run again in 2015 for more information contact Cynthia Ugochukwu via email Cynthia.ugochukwu@ouh.nhs.uk

Oxford University Hospital Trust 

Similar stories

New blood-based test is the first ever to simultaneously identify if a patient has cancer and if it has spread

A publication by University of Oxford researchers describes a new minimally invasive and inexpensive blood test that can identify cancer in patients with non-specific symptoms. The early success of this technology makes it the first blood-based test that not only detects cancer in this population but can simultaneously identify if a cancer has spread.

Alan Davidson Foundation supports ground-breaking Motor Neurone Disease research

A £210,000 donation from the Alan Davidson Foundation (ADF) has been made to the Nuffield Department of Clinical Neurosciences (NDCN) to advance the University’s world leading research into Motor Neurone Disease (MND). The funding will support a project manager for three years to deliver an innovative research project using the genetic causes of MND to develop approaches to early diagnosis and eventually, prevention of all forms of MND.

New Oxford-GSK Institute to harness advanced technology and unravel mechanisms of disease

GlaxoSmithKline plc and the University of Oxford today announced a major five-year collaboration to establish the Oxford-GSK Institute of Molecular and Computational Medicine.

Jenner Institute named Covid Innovation Heroes

The team at the University of Oxford’s Jenner Institute has been celebrated for their global pandemic work by The Oxford Trust’s Covid Innovation Heroes Award­ 2021.

Oxford joins consortium to advance quantum drug discovery with £6.8M grant from Innovate UK

Oxford University today joins a consortium led by the digital quantum computing company, SEEQC, to build and deliver a full-stack quantum computer for pharmaceutical drug development for Merck KGaA.

AIMday in Women's Health - registration for academics now open

Are you an academic interested in finding out how your knowledge can be used to solve industry challenges? Would you like to widen your network? Meet potential collaborators / future employees? Gain insights into relevant funding schemes? If you answer YES to any of the above, now is the time to register for the AIMday in Women's Health.